Regulus Therapeutics Inc (NASDAQ:RGLS)

12.86
Delayed Data
As of 10:27am ET
 +0.1099 / +0.86%
Today’s Change
6.08
Today|||52-Week Range
25.60
-19.83%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close12.75
Today’s open12.74
Day’s range12.71 - 13.01
Volume18,098
Average volume (3 months)586,463
Market cap$650.5M
Dividend yield--
Data as of 10:27am ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+15.64%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.07+0.48%
ADXSAdvaxis Inc+0.35+1.52%
OMEDOncoMed Pharmaceutic...+0.40+1.75%
--China Health Group I...0.000.00%
Data as of 10:43am ET, 05/22/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Kleanthis G. Xanthopoulos
Vice President-Finance &
Accounting
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers